These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11576533)

  • 21. Role of the gp85/trans-sialidase superfamily of glycoproteins in the interaction of Trypanosoma cruzi with host structures.
    Alves MJ; Colli W
    Subcell Biochem; 2008; 47():58-69. PubMed ID: 18512341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trypanosoma cruzi uses a 45-kDa mucin for adhesion to mammalian cells.
    Turner CW; Lima MF; Villalta F
    Biochem Biophys Res Commun; 2002 Jan; 290(1):29-34. PubMed ID: 11779128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.
    Rosenberg CS; Zhang W; Bustamante JM; Tarleton RL
    Infect Immun; 2016 Sep; 84(9):2627-38. PubMed ID: 27354447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rab5 activation by Toll-like receptor 2 is required for Trypanosoma cruzi internalization and replication in macrophages.
    Maganto-Garcia E; Punzon C; Terhorst C; Fresno M
    Traffic; 2008 Aug; 9(8):1299-315. PubMed ID: 18445119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trans-sialidase overcomes many antigens to be used as a vaccine candidate against Trypanosoma cruzi.
    Bontempi I; Fleitas P; Poato A; Vicco M; Rodeles L; Prochetto E; Cabrera G; Beluzzo B; Arias D; Racca A; Guerrero S; Marcipar I
    Immunotherapy; 2017 Jun; 9(7):555-565. PubMed ID: 28595515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative transcriptome profiling of virulent and non-virulent Trypanosoma cruzi underlines the role of surface proteins during infection.
    Belew AT; Junqueira C; Rodrigues-Luiz GF; Valente BM; Oliveira AER; Polidoro RB; Zuccherato LW; Bartholomeu DC; Schenkman S; Gazzinelli RT; Burleigh BA; El-Sayed NM; Teixeira SMR
    PLoS Pathog; 2017 Dec; 13(12):e1006767. PubMed ID: 29240831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections.
    Leguizamón MS; Campetella O; Russomando G; Almiron M; Guillen I; Ganzález Cappa SM; Frasch AC
    J Infect Dis; 1994 Dec; 170(6):1570-4. PubMed ID: 7995998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trypanosoma cruzi recognition by macrophages and muscle cells: perspectives after a 15-year study.
    De Araujo-Jorge TC; Barbosa HS; Meirelles MN
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():43-56. PubMed ID: 1342716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Living dangerously: how Trypanosoma cruzi uses lysosomes to get inside host cells, and then escapes into the cytoplasm.
    Andrews NW
    Biol Res; 1993; 26(1-2):65-7. PubMed ID: 7670547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages.
    Risso MG; Garbarino GB; Mocetti E; Campetella O; Gonzalez Cappa SM; Buscaglia CA; Leguizamon MS
    J Infect Dis; 2004 Jun; 189(12):2250-9. PubMed ID: 15181573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The trans-sialidase, the major Trypanosoma cruzi virulence factor: Three decades of studies.
    Freire-de-Lima L; Fonseca LM; Oeltmann T; Mendonça-Previato L; Previato JO
    Glycobiology; 2015 Nov; 25(11):1142-9. PubMed ID: 26224786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of a model trisaccharide for studying the interplay between the anti α-Gal antibody and the trans-sialidase reactions in Trypanosoma cruzi.
    Giorgi ME; Lopez R; Agusti R; Marino C; de Lederkremer RM
    Carbohydr Res; 2017 Oct; 450():30-37. PubMed ID: 28858610
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arginine decarboxylase inhibitors reduce the capacity of Trypanosoma cruzi to infect and multiply in mammalian host cells.
    Kierszenbaum F; Wirth JJ; McCann PP; Sjoerdsma A
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4278-82. PubMed ID: 3295879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cardiomyocyte mannose receptor system is involved in Trypanosoma cruzi invasion and is down-modulated after infection.
    Soeiro Mde N; Paiva MM; Barbosa HS; Meirelles Mde N; Araújo-Jorge TC
    Cell Struct Funct; 1999 Jun; 24(3):139-49. PubMed ID: 10462176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuraminidase from Trypanosoma cruzi: analysis of enhanced expression of the enzyme in infectious forms.
    Harth G; Haidaris CG; So M
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8320-4. PubMed ID: 3120189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial cell signalling induced by trans-sialidase from Trypanosoma cruzi.
    Dias WB; Fajardo FD; Graça-Souza AV; Freire-de-Lima L; Vieira F; Girard MF; Bouteille B; Previato JO; Mendonça-Previato L; Todeschini AR
    Cell Microbiol; 2008 Jan; 10(1):88-99. PubMed ID: 17672865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trans-sialidase delivered as a naked DNA vaccine elicits an immunological response similar to a Trypanosoma cruzi infection.
    Costa F; Pereira-Chioccola VL; Ribeirão M; Schenkman S; Rodrigues MM
    Braz J Med Biol Res; 1999 Feb; 32(2):235-9. PubMed ID: 10347760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The binding of CCL2 to the surface of Trypanosoma cruzi induces chemo-attraction and morphogenesis.
    Yamauchi LM; Aliberti JC; Baruffi MD; Portela RW; Rossi MA; Gazzinelli RT; Mineo JR; Silva JS
    Microbes Infect; 2007 Jan; 9(1):111-8. PubMed ID: 17194609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trypanosoma cruzi: parasite shed vesicles increase heart parasitism and generate an intense inflammatory response.
    Trocoli Torrecilhas AC; Tonelli RR; Pavanelli WR; da Silva JS; Schumacher RI; de Souza W; E Silva NC; de Almeida Abrahamsohn I; Colli W; Manso Alves MJ
    Microbes Infect; 2009 Jan; 11(1):29-39. PubMed ID: 19028594
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.